Symptomatic corpus luteum hemorrhage in adolescent females with ITP

Eur J Pediatr. 2024 Jul;183(7):2893-2897. doi: 10.1007/s00431-024-05560-0. Epub 2024 Apr 11.

Abstract

Patients with immune thrombocytopenia (ITP) usually present with minor mucocutaneous bleeding. Corpus luteum hemorrhage (CLH) is generally asymptomatic but may, rarely, lead to severe intraperitoneal bleeding, mostly in patients with coagulation disorders. CLH causing intraperitoneal bleeding has only been described in few individuals with ITP. The objective of this retrospective observational study was to assess the clinical course and incidence of symptomatic CLH in adolescent females with newly diagnosed or chronic ITP. Additionally, a comprehensive literature review was conducted to scrutinize cases of pediatric female patients with ITP, complicated by CLH. We identified three patients with ITP and hemoperitoneum secondary to CLH. They presented with acute abdominal pain, had severe thrombocytopenia (platelet counts below 20 × 109/L), and required blood transfusions as well as ITP-directed therapy. All the patients were hemodynamically stable and did not require emergency surgical intervention. Conclusion: CLH could potentially pose a significant complication in the context of adolescent females with ITP, requiring a strong index of suspicion to direct expedient therapy. What is Known: • Immune thrombocytopenia is typically associated with minor bleeding tendency. • Corpus luteum hemorrhage is generally asymptomatic; however, in women with bleeding disorders, it has the potential to result in substantial intra-abdominal bleeding. What is New: • Corpus luteum hemorrhage leading to intra-abdominal bleeding is a potential severe complication of immune thrombocytopenia in adolescent females.

Keywords: Bleeding; Corpus luteum hemorrhage; ITP; Thrombocytopenia.

Publication types

  • Observational Study
  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Corpus Luteum*
  • Female
  • Hemoperitoneum / etiology
  • Hemorrhage* / diagnosis
  • Hemorrhage* / etiology
  • Hemorrhage* / therapy
  • Humans
  • Ovarian Diseases / diagnosis
  • Ovarian Diseases / etiology
  • Purpura, Thrombocytopenic, Idiopathic* / complications
  • Purpura, Thrombocytopenic, Idiopathic* / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic* / therapy
  • Retrospective Studies